Christopher Weil & Company Core Investment Fund
CWCFX
September 30, 2024
Ticker
CWCFX
Fund AUM
$70M
Category
Large-Blend
Benchmark
S&P 500 Index
Active Share Number
92.77
1
1
Characteristics derived from FactSet
The Christopher Weil & Company Core Investment Fund team integrates the tenants of several investment styles resulting in our own nuanced investment philosophy. When looking for investments, we seek companies with the following characteristics:
-
Strong Free Cash Flow Yields and a growing need for the company’s services
-
Management teams that allocate capital well and are aligned with stakeholders
-
Investments with an eye on demographic trends and macro-economic backdrops that we believe are important going forward
-
Potential turnaround stories with multiple levers to unlock value
-
Capitalizations that range from micro-cap to mega-cap
An added component of our philosophy is seeking ways to use cash, ETF's, as well as call and put options, opportunistically.
As of 9/30/24, CWCFX
was rated 2, 1, 3, and 2 stars
for the Overall, 3-, 5-, and 10-
year periods against 1,063;
1,292; 1,189; and 895 Large-
Blend funds, based on risk-
adjusted returns respectively,
by Morningstar™️. See
disclosures for details
September 30, 2024
About CWCFX
A non-diversified fund that seeks long-term capital appreciation by investing in what we believe to be undervalued securities of companies with market capitalizations exceeding $1 billion.
Portfolio Management
Michael Hubbert, CIMA®
Portfolio Manager
Investment Officer, Public Markets
20 years in the industry
With the firm since 2016
Contact: cwcfx@cweil.com
John Wells
Portfolio Manager,
Chief Investment Officer
President & Chief Executive Officer
31 years in the industry
With the firm since 1991
Christopher Weil & Company, Inc., Fund Advisor
An investor should carefully consider a Fund’s investment objective, risks, charges, and expenses before investing. A Fund’s prospectus and summary prospectus contain this and other information about the Christopher Weil & Company Core Investment Fund. To obtain the Fund’s prospectus and summary prospectus call 1-888-550-9266 or visit our website at www.cweil.com/cwcfx. A Fund’s prospectus and summary prospectus should be read carefully before investing.
© [2022] Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
The Morningstar Rating™ for funds, or "star rating", is calculated for managed products (including mutual funds, variable annuity and variable life subaccounts, exchange-traded funds, closed-end funds, and separate accounts) with at least a three-year history. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a managed product's monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The Morningstar Rating does not include any adjustment for sales loads. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating for a managed product is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total returns, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total returns. While the 10-year overall star rating formula seems to give the most weight to the 10- year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods.
The Morningstar Style Box™
The Morningstar Style Box™ reveals a fund’s investment strategy. For equity funds the vertical axis shows the market capitalization of the long stocks owned and the horizontal axis shows investment style (value, blend, or growth). A darkened square in the stylebox indicates the weighted average style of the portfolio.
Morningstar Ownership Zone™
The Morningstar Ownership Zone™ provides detail about a portfolio’s equity investment style by showing the range of stock sizes and styles. A portfolio's Ownership Zone is derived by plotting each stock in the fund's portfolio within the proprietary Morningstar Style Box™. The shaded area represents the center 75% of the fund’s assets, and it provides an intuitive visual representation of the area of the market in which the fund invests. A “centroid” plot in the middle of the Ownership Zone represents the weighted average of all the fund's holdings. A fund that is concentrated will have a small ownership zone relative to the area of the style box, and broadly diversified fund will have an ownership zone that stretches across many sizes and style. Over a period of time, the shape and location of a fund's ownership zone may vary.
Definitions
Alpha: Alpha is a measure of performance on a risk-adjusted basis. Alpha takes the volatility (price risk) of a security or mutual fund and compares its risk-adjusted performance to a benchmark index. The excess return of the security or fund relative to the return of the benchmark index is a fund's alpha. Beta: Beta measures the relationship between the portfolio's excess return over T-bills (representing a risk-free rate) relative to the excess return of the portfolio's benchmark. A low beta does not imply that the portfolio has a low level of volatility; rather, a low beta means that the portfolio's market-related risk is low. Beta is often referred to as systematic risk. Downside Capture Ratio: The downside capture ratio measures a manager's performance in down markets relative to a particular benchmark. A down market is one in which the market's quarterly (or monthly) return is less than zero. For example, a ratio of 50% means that the portfolio's value fell half as much as its benchmark index during down markets. Morningstar Large-Blend Category: Large-blend portfolios are fairly representative of the overall US stock market in size, growth rates and price. Stocks in the top 70% of the capitalization of the US equity market are defined as large cap. The blend style is assigned to portfolios where neither growth nor value characteristics predominate. These portfolios tend to invest across the spectrum of US industries, and owing to their broad exposure, the portfolios' returns are often similar to those of the S&P 500 Index. R-squared: R-squared is generally interpreted as the percentage of a fund or security's movements that can be explained by movements in a benchmark index. A high R-squared, between 85% and 100%, indicates the stock or fund's performance moves relatively in line with the index. Sharpe Ratio: The Sharpe ratio is calculated using standard deviation and excess return to determine reward per unit of risk. The higher the Sharpe ratio, the better the portfolio's historical risk-adjusted performance. Standard Deviation: Annualized standard deviation is a measure of the dispersion of a set of data from its mean. The more spread apart the data, the higher the deviation. Standard deviation is calculated as the square root of variance. Upside Capture Ratio: The upside capture ratio is a measure of a manager's performance in up markets relative to a particular benchmark. An up market is one in which the market's quarterly (or monthly) return is greater than or equal to zero. For example, a ratio of 50% means that the portfolio's value increased half as much as its benchmark index during up markets.
Important Risk Information: Risk of Non-Diversification: The Fund is a non-diversified portfolio, which means that it has the ability to take larger positions in a smaller number of securities than a portfolio that is "diversified.” Non-diversification increases the risk that the value of the Fund could go down because of the poor performance of a single investment. Risks of Small and Medium Capitalization Companies: The Fund invests in the stocks of small and medium capitalization companies, which may subject the Fund to additional risks. The earnings and prospects of these companies are more volatile than larger companies. Small and medium capitalization companies may have limited product lines and markets and may experience higher failure rates than do larger companies. Risks of Investing in Undervalued Securities: Undervalued securities are, by definition, out of favor with investors, and there is no way to predict when, if ever, the securities may return to favor. Therefore, investors should purchase shares of the Fund only if they intend to be patient, longterm investors. Sector Risks: Sector risk is the possibility that stocks within the economic sector will decline in price due to sector specific market or economic developments. If the Adviser invests a significant portion of the Fund's assets in a particular sector, the Fund is subject to the risk that companies in the same sector are likely to react similarly to adverse legislative or regulatory changes, adverse market conditions, and/or increased competition affecting that market segment. The Fund may emphasize certain sectors at various times including, among others, information technology and health care. Risks associated with investments in companies in the information technology sector include their technology becoming obsolete, short product cycles, decreasing margins and profits, and competition from new market entrants. Risks associated with investments in companies in the healthcare sector may include government regulation, policy changes and reimbursement rates, as well as government approval of products and services. Further, types of products or services produced or provided by healthcare companies quickly can become obsolete. Pharmaceutical companies and other companies can be affected by patent expirations.
This communication may contain privileged and confidential information; people other than the addressee should not review, distribute or duplicate it without permission. Nothing in this communication constitutes a solicitation by us for the purchase or sale of any securities. We do not accept account orders or instructions by e-mail, and will not be responsible for carrying out e-mailed orders or instructions. We provide reports as an accommodation to help you monitor your investment activity; securities pricing may not reflect reliable values. In the event of a discrepancy, the information in your confirmations of daily activity and monthly statement of account shall govern. While the information in this communication comes from sources believed to be reliable as of today, we make no representation as to its accuracy and completeness and provide no assurances as to future returns or performance. We may own positions in securities mentioned in this communication.
You may obtain a prospectus for WEIL's mutual funds by calling us toll-free at 1-888-550-9266 or visiting www.cweil.com. The prospectus should be read carefully before investing. WEIL's mutual funds are distributed by Arbor Court Capital, LLC — Member FINRA / SIPC. Nothing herein should be construed as legal or tax advice. You should consult an attorney or tax professional regarding your specific legal or tax situation. Christopher Weil & Company, Inc. may be contacted at 800.355.9345 or info@cweil.com